Atherotech atherotech.com


Atherotech is a cardio-diagnostic company focusing on direct measurement of the comprehensive lipid profile using the company's VAP (Vertical Auto Profile) technology. The VAP technology is a patented density gradient ultracentrifugation that directly measures the cholesterol content of all lipids, components, and subclasses. The company provides its unique testing services to physicians, hospitals, clinics, and other laboratories throughout the United States. Atherotech is a CLIA approved clini...Show all

Atherotech is a cardio-diagnostic company focusing on direct measurement of the comprehensive lipid profile using the company's VAP (Vertical Auto Profile) technology. The VAP technology is a patented density gradient ultracentrifugation that directl...Show all

Company (Alive / Active)

Phone: 205-314-7400

Fax:

201 London Parkway

Birmingham, 35211
Alabama, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Atherotech $27.2M Jul 9, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Atherotech Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Industry VenturesDebt & Specialty FinanceSan Francisco, California, United StatesOther Investors
Compass Technology PartnersVenture CapitalPalo Alto, California, United StatesSeries E, Series D, Unattributed VC
J.F. Shea Venture CapitalVenture CapitalWalnut, California, United StatesUnattributed VC
Jemison Investment CompanyHolding CompanyBirmingham, Alabama, United StatesSeries E
Greer Capital AdvisorsPrivate EquityBirmingham, Alabama, United StatesSeries E
See all 9 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Measurement of serum lipoproteins Jan 11, 2016 Jul 11, 2017 Patent
Measurement of serum lipoproteins Jun 17, 2013 Jul 11, 2017 Patent
Measurement of serum lipoproteins Mar 15, 2013 Jan 19, 2016 Patent
Methods for determining the risk of coronary heart disease and clinical manifestations of coronary heart disease Mar 13, 2012 Jul 01, 2014 Patent
Apo b measurement system and method Apr 20, 2007 Apr 21, 2009 Patent
See all 9 patents